Alexion Pharmaceuticals 10Q 2019 Q1 Quarterly report | ALXN Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: absorbed, accidental, Affibody, affiliated, aggressive, AL, ALS, Amgen, amplified, amyloid, Amyotrophic, analyst, antitrust, appeal, art, assumption, ASU, bivalent, brand, bulk, Caelum, capability, ceased, cGCP, chest, Chugai, CMO, collateralized, compelling, composition, concept, conclusion, conclusive, conference, Congressional, constant, Copenhagen, counsel, countered, counterfeit, coupled, denial, denied, Denmark, derecognition, diagnostic, distributor, diverse, diversify, diversifying, donated, embedded, enlarged, estate, evidence, excellence, exemption, exploratory, facilitate, facilitating, fainting, fleet, frequent, frequently, GAAP, GCP, GK, GLP, goal, hereof, highlighted, illegally, implicit, index, inherently, injury, inquired, inventorship, investor, IPO, IPR, jeopardizing, joint, largest, leave, lessee, lifetime, light, Lira, loading, logistic, mAb, match, million, moot, MRNA, Nasdaq, NORD, ODD, organizational, paragraph, parking, pathogenic, pattern, PD, peptide, petitioned, PLEX, PMDA, point, possession, preceding, premium, prepaid, pressure, prompt, proof, prove, PSI, PTO, real, reallocation, recipient, recover, regime, reluctance, rendering, rent, repay, repeal, rigid, Rodino, satisfactorily, shorter, Singapore, slight, societal, solve, Spain, spleen, subsidiary, substance, suggesting, Sunshine, superior, symbol, syncope, tachycardia, tampered, tampering, teaching, team, telephonic, temperature, tied, Tokyo, transported, trend, Turkish, undisclosed, undiscounted, Union, unrecognized, unspecified, unveiled, vigorously, WAIHA, yield, Zealand

Removed: account, administering, adolescent, advanced, Affordable, anniversary, annum, assertion, assessed, attributed, avoidance, bad, baseline, bifurcation, biology, breakthrough, buying, cancel, captive, charged, circumstance, clarified, Code, collected, collectibility, computation, consignment, constrain, constrained, coordinating, core, correctly, Cosmetic, create, creditworthy, damaged, de, deductible, deemed, defray, deliver, destroyed, detail, discontinuation, disposed, distinct, dose, doubtful, eculizamab, enactment, encourage, enrolling, enterprise, epidemic, epidemiology, essential, estimating, estimation, examining, existed, extension, Factor, favored, feet, fit, formulate, framework, Franc, freight, fulfilment, funded, GILTI, good, Haven, heading, hemoglobin, HHS, historic, HRSA, HTA, implied, incident, initially, insignificant, integrated, intention, intentionally, interpretive, interrupt, introduced, landlord, Latin, launched, LDH, legally, length, longitudinal, maintained, mandate, marker, marrow, maximize, medicinal, notable, numeric, nurse, obligate, occurrence, occurring, outbound, outflow, participated, partnership, passed, penalized, people, post, postpone, prepayment, professional, prohibited, promised, promulgated, proportion, provisional, rarity, rating, recalled, recognizing, referred, reflected, refunded, refuse, register, registration, regular, relocate, remitted, renewal, repaid, resolved, rest, reversal, rounding, Ruble, rule, rulemaking, Russian, satisfied, secondary, separately, shared, shipping, simplify, space, square, stabilized, statutorily, temporary, thirteenth, threat, transferring, transfusion, transparency, transplant, Trump, unavailable, understand, unremitted, utility, utilization, vaccinated, Variability, warranted, withdrawn



Dated:	April 25, 2019	/s/ LUDWIG N. HANTSON, Ph.D.
		Chief Executive Officer


(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Alexion Pharmaceuticals (ALXN) 10-Q2019 Q1 Quarterly report

Content analysis